BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.49% | 6.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.49% | 6.22% | |||
| Cost of Revenue | 21.14% | -7.04% | |||
| Gross Profit | 2.89% | 55.80% | |||
| SG&A Expenses | -36.92% | 50.62% | |||
| Depreciation & Amortization | 24.53% | -22.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.94% | 12.42% | |||
| Operating Income | 68.91% | -35.71% | |||
| Income Before Tax | 45.38% | 10.40% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 45.38% | 10.40% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 45.38% | 10.40% | |||
| EBIT | 68.91% | -35.71% | |||
| EBITDA | 66.89% | -57.35% | |||
| EPS Basic | 45.38% | 10.53% | |||
| Normalized Basic EPS | 59.80% | -22.89% | |||
| EPS Diluted | 50.00% | 1.35% | |||
| Normalized Diluted EPS | 59.80% | -22.89% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
